Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia
Clinical trial NCT02281500 · COMPLETED
Trial details
- NCT number
- NCT02281500
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-22
- Primary completion
- 2019-11-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.